InvestorsHub Logo
Followers 0
Posts 1
Boards Moderated 0
Alias Born 09/04/2021

Re: None

Saturday, 09/04/2021 9:44:31 PM

Saturday, September 04, 2021 9:44:31 PM

Post# of 76
WEBINAR ON ERYASPASE IN PANCREATIC CANCER (SEPTEMBER 1, 2021)

ERYTECH TO PARTICIPATE IN THE CITI 16TH ANNUAL BIOPHARMA CONFERENCE
(September 8 2021 through September 10, 2021)

ERYTECH HOSTING KEY OPINION LEADER WEBINAR ON ERYASPASE IN PANCREATIC CANCER
ERYTECH Hosting Key Opinion Leader Webinar on Eryaspase in Pancreatic Cancer
(September 1 2021)

ERYTECH GRANTED U.S. FDA FAST TRACK DESIGNATION FOR ERYASPASE IN HYPERSENSITIVE ALL
(July 29, 2021)

Erytech is starting the push for sales, fda approval by the end of the month if not sooner. After fda approval eryteck will hit the ceiling.